Milrinone

Primacor (milrinone) is a small molecule pharmaceutical. Milrinone was first approved as Primacor on 1987-12-31. It is used to treat heart failure in the USA. The pharmaceutical is active against cGMP-inhibited 3',5'-cyclic phosphodiesterase A. In addition, it is known to target cGMP-specific 3',5'-cyclic phosphodiesterase, cGMP-inhibited 3',5'-cyclic phosphodiesterase B, cGMP-dependent 3',5'-cyclic phosphodiesterase, and transthyretin.